Department of Immunohematology and Blood Transfusion, Leiden University Medical Center
Affiliated withLeiden University Medical CenterLeiden University Medical Center
Research Area
Guillaume began his studies at the High Preparatory School in Biology in France, from which he holds MSc in Biotechnology in 2012. He worked four years for Novartis and UCB where he worked at the Center of Expertise for Biologics in Switzerland. Currently working as a Marie Curie Early stage researcher at the University of Leiden in The Netherlands, he is completing his PhD in Tumor Immunology, researching the cellular mechanisms of effective immunotherapy in solid tumors. His focus is in bridging the most advanced single cell technologies with tumor immunology challenges to unravel the complex cellular patterns behind immunotherapy and bringing precision medicine routinely to the clinic.
Article Total : 1 | Year |
|---|---|
![]() Publication title Cited by 5 | 2019 |
Article | Year |
|---|---|
Cytomegalovirus infection and progressive differentiation of effector-memory T cells. F1000Research| PubMed ID: 30345004 | 2018 |
: A workflow for visual and quantitative analysis of flow and mass cytometry data to discover immune signatures and correlations. Computational and structural biotechnology journal| PubMed ID: 30450167 | 2018 |
PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory receptors. Journal for immunotherapy of cancer| PubMed ID: 31412943 | 2019 |